期刊文献+

舒洛地特对高糖环境中大鼠肾小球系膜细胞CD36抗原表达的抑制作用研究

Inhibitory Effects of Sulodexide on Expression of CD36 in Rat Glomerular Mesangial Cells Cultured in High Glucose
下载PDF
导出
摘要 目的:观察舒洛地特对高糖培养基中大鼠肾小球系膜细胞CD36抗原表达的抑制作用,探讨舒洛地特对肾脏的保护作用。方法:培养大鼠肾小球系膜细胞24 h后,将培养的细胞分为对照组(C组,普通培养基,含5.6 mmol·L^(-1)葡萄糖),甘露醇组(M组,24.2 mmol·L^(-1)甘露醇+C组),高糖组(H组,30 mmol·L^(-1)高糖MEM培养基)、舒洛地特干预组(S组,H组+1.0 LRU·ml^(-1)舒洛地特)。培养24 h后,RT-PCR和Western blotting法检测各组CD36 mRNA及蛋白的表达。结果:对照组和甘露醇组CD36mRNA(0.24±0.07和0.21±0.06)及蛋白(0.26±0.08和0.22±0.07)的表达差异无统计学意义(P>0.05),高糖组CD36 mRNA(0.62±0.11和0.24±0.07)及蛋白(0.83±0.23和0.26±0.08)表达显著高于对照组,差异有统计学意义(P<0.05),舒洛地特干预组CD36 mRNA(0.36±0.13和0.62±0.11)及蛋白(0.42±0.15和0.83±0.23)表达显著低于高糖组,差异有统计学意义(P<0.05)。结论:舒洛地特可抑制高糖环境中大鼠肾小球系膜细胞CD36抗原的表达,可能是舒洛地特发挥肾脏保护作用的机制之一。 Objective:To investigate the inhibitory effects of sulodexide on the expression of CD36 induced by high glucose in rat glomerular mesangial cells.Method:The mesangial cells were cultured for 24 hours and then divided into 4 groups;the control group(C,5.6 mmol?L-1 glucose),mannitol group(M,24.2 mmol?L-1 mannitol + group C);high glucose group(H,30 mmol?L-1 glucose) and sulodexide group(S,group H + 1.0 LRU·ml-1 sulodexide).The expression of CD36 were detected by RT-PCR and Western blotting.Result:No significant difference in CD36 was found between group C and group M with mRNA of(0.24 ±0.07) and(0.21 ±0.06)(P&gt;0.05)and protein level of(0.26 ±0.08) and(0.22 ±0.07)(P &gt;0.05),respectively;Comparing with that in group C,the expression of CD36 in group H was increased markedly with mRNA of(0.62 ±0.11) and(0.24 ± 0.07)(P &lt; 0.05) and protein level of(0.83 ±0.23) and(0.26 ±0.08)(P &lt;0.05),respectively,and that was decreased markedly in group S compared with that in group H with mRNA of(0.36 ±0.13) and(0.62 ±0.11)(P &lt;0.05)and protein level of(0.42 ±0.15) and(0.83± 0.23)(P &lt;0.05),respectively.Conclusion;Sulodexide can inhibit the expression of CD36 in rat glomerular mesangial cells under high glucose condition,which may be one of the mechanisms of kidney protective function.
出处 《中国药师》 CAS 2013年第12期1778-1781,共4页 China Pharmacist
关键词 舒洛地特 CD36抗原 肾小球系膜细胞 Sulodexide Scavenger receptor CD36 Glomerular mesangial cells
  • 相关文献

参考文献11

二级参考文献30

  • 1包艳,贾汝汉,袁军,李竞,叶迎春,孙永林,王颖.罗格列酮对糖尿病大鼠肾脏保护作用机制的探讨[J].中华肾脏病杂志,2007,23(4):224-229. 被引量:18
  • 2李兴,张木勋.Expression of c-met Stimulated by High Glucose in Human Renal Tubular Epithelial Cells and Its Implication[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2007,27(2):161-163. 被引量:9
  • 3Schnaper HW, Hayashida T, Hubchak SC, et al. TGF-beta signal transduction and mesangial cell fibrogenesis [ J]. Am J Physiol Renal Physiol, 2003,284 (2) : 243 -252.
  • 4Weigert C ,Sauer U, Brodbeck K,et al. AP-1 proteins mediate hyperglycemia-induc.ed activation of the human TGF-beta1 promoter in mesangial cells [ J ]. J Am Soc Nephrol,2000,11( 11 ) :2007-2016.
  • 5Ha H,Lee HB. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney[JJ. Nephrology (Carlton), 2005,10 (Suppl) :S7 - 10.
  • 6Ma LJ, Marcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats[J]. Kidney Int,2001,59(5) :1899-910.
  • 7Bagi Z, Koller A, Kaley G. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes [ J ]. Am J Physiol Heart Circ Physiol,200d-,286 (2) :742-748.
  • 8Villegas I, Martin AR, Toma W, et al.Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemla-reperfusion damage in rats : role of oxygen free radicals generation [ J ]. Eur J Pharma[J]. col,2004,505 ( 1-3 ) : 195 -203.
  • 9Collino M, Aragno M, Mastrocola R,et al. Modulation of the oxidative stress and inflammatory resporrse by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion[ J]. Eur J Pharmacol,2006,530(1-2) :70-80.
  • 10肖湘成,周巧玲.罗格列酮对高糖作用下人肾小管上皮细胞增殖的影响[J].医学临床研究,2007,24(9):1533-1535. 被引量:2

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部